drugset / Trial / NCT02297763

Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients

NCT02297763

Phase 3 Unknown 194 enrolled Seoul National University Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to evaluate the efficacy of low dose quetiapine for the prophylaxis of delirium in critically ill patients in medical intensive care unit.

Timeline

Start
2015-03
Primary completion
2016-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Quetiapine Small molecule 12.5 mg
Comparator Quetiapine Small molecule 25 mg

Indications